Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease

Table 1 Median and range of the EliA^™ TRAb values in different groups of patients

Disease	No.	ELiA^™ TRAb (median IU/L)	Range (minimum–maximum)	Significant difference from NC (p)
u-GD	57	10.0	0.7− > 50	< 0.0001
t-GD	34	5.95	1.6− > 50	< 0.0001
GD/GO	15	16.3	2.2− > 50	< 0.0001
NTMG	52	1.4	0.6–2.3	ns
TA/TMG	20	1.3	1.0–3.3	ns
HT	86	1.1	0.1–2.7	ns
NTAD	55	2.2	1.0–4.4	ns
NC	120	1.4	0.7–3.8	ns
Overall	439

u-GD Graves’ disease before treatment, t-GD GD on treatment, GD/GO Graves’ patients with orbitopathy, NTMG multinodular non-toxic goiter, TA/TMG toxic adenoma/toxic multinodular goiter, HT Hashimoto’s thyroiditis, NTAD non-thyroid autoimmune diseases, NC normal controls

ISSN: 2038-3274